ArticleProbiotics and antimicrobial proteins2026
Ligilactobacillus salivarius Lbs57 Exerted Antibacterial Activity and Modulated Cecal Microbiota to Reduce Foodborne Pathogen Campylobacter jejuni.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Campylobacter jejuni (C. jejuni) remains a major global foodborne pathogen, with poultry serving as a primary reservoir. This study evaluates the probiotic potential of Ligilactobacillus salivarius Lbs57 against foodborne pathogen C. jejuni. In vitro, the L. salivarius Lbs57 cell-free supernatant (CFS) exhibited broad-spectrum, thermostable antibacterial activity, with the strongest inhibition against C. jejuni. Characterization revealed the activity was pH and protease-sensitive, and resistant to chemical detergents. Multi-omics analysis, including whole-genome sequencing and peptidomics, identified a two-peptide bacteriocin, salivaricin, as the key antimicrobial agent. In chickens, prophylaxis, continuous, and post-colonization interventions significantly reduced C. jejuni cecal colonization, with achieving a 3-log reduction. Furthermore, L. salivarius Lbs57 modulated the cecal microbiota by increasing diversity and enriching beneficial genera (e.g., Bacteroides, Faecalibacterium) while suppressing pathogens like Clostridium and Streptococcus. Overall, these findings highlight the efficacy of L. salivarius Lbs57 is a promising probiotic candidate for limiting C. jejuni and enhancing gut health in poultry.
Indexed as
Identifiers
42397539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.